Caroline E. Visser

6.8k total citations · 1 hit paper
63 papers, 4.8k citations indexed

About

Caroline E. Visser is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Caroline E. Visser has authored 63 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 23 papers in Infectious Diseases and 14 papers in Clinical Biochemistry. Recurrent topics in Caroline E. Visser's work include Bacterial Identification and Susceptibility Testing (14 papers), Antibiotic Use and Resistance (8 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Caroline E. Visser is often cited by papers focused on Bacterial Identification and Susceptibility Testing (14 papers), Antibiotic Use and Resistance (8 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Caroline E. Visser collaborates with scholars based in Netherlands, United States and Germany. Caroline E. Visser's co-authors include Ed J. Kuijper, J. F. W. M. Bartelsman, Max Nieuwdorp, Josbert J. Keller, Els van Nood, Peter Speelman, Willem M. de Vos, Marcel G. W. Dijkgraaf, Anne Vrieze and Susana Fuentes and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Biomaterials.

In The Last Decade

Caroline E. Visser

61 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

2013 2.7k citations Caroline E. Visser, Ed J. Kuijper et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caroline E. Visser Netherlands	26	3.1k	2.2k	1.8k	757	629	63	4.8k
Boualem Sendid France	41	2.7k 0.9×	2.8k 1.2×	1.6k 0.9×	470 0.6×	453 0.7×	151	5.6k
Ying Taur United States	35	3.6k 1.1×	1.6k 0.7×	4.6k 2.6×	541 0.7×	525 0.8×	93	7.8k
Sahil Khanna United States	46	4.3k 1.4×	3.3k 1.5×	1.9k 1.1×	1.3k 1.7×	1.4k 2.2×	270	6.5k
Asia Gobourne United States	9	2.2k 0.7×	784 0.3×	3.0k 1.7×	437 0.6×	372 0.6×	10	4.6k
Theodore S. Steiner Canada	34	2.3k 0.7×	975 0.4×	1.1k 0.6×	340 0.4×	426 0.7×	97	5.9k
Nina Langeland Norway	41	2.3k 0.7×	1.6k 0.7×	620 0.4×	239 0.3×	340 0.5×	231	6.1k
Alexander Swidsinski Germany	40	1.7k 0.5×	2.0k 0.9×	4.5k 2.6×	764 1.0×	1.4k 2.2×	80	8.4k
Susana Fuentes Netherlands	10	2.8k 0.9×	1.4k 0.6×	2.4k 1.4×	1.1k 1.4×	630 1.0×	16	4.1k
Robert R. Jenq United States	36	2.5k 0.8×	1.0k 0.4×	4.0k 2.3×	486 0.6×	527 0.8×	116	6.8k
S. Tabaqchali United Kingdom	40	1.9k 0.6×	1.3k 0.6×	858 0.5×	454 0.6×	1.5k 2.4×	154	5.0k

Countries citing papers authored by Caroline E. Visser

Since Specialization

Citations

This map shows the geographic impact of Caroline E. Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline E. Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline E. Visser more than expected).

Fields of papers citing papers by Caroline E. Visser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline E. Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline E. Visser. The network helps show where Caroline E. Visser may publish in the future.

Co-authorship network of co-authors of Caroline E. Visser

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline E. Visser. A scholar is included among the top collaborators of Caroline E. Visser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline E. Visser. Caroline E. Visser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Visser, Caroline E., et al.. (2023). Population pharmacokinetic/pharmacodynamic target attainment of ceftriaxone 2 g once daily in non‐critically ill hospitalized adult patients during the acute phase of infection. British Journal of Clinical Pharmacology. 89(11). 3262–3272.

Wágner, Robert, et al.. (2023). Surprise positive culture rate in the treatment of presumed aseptic long-bone nonunion: a systematic review with meta-analysis of 2397 patients. Archives of Orthopaedic and Trauma Surgery. 144(2). 701–721. 7 indexed citations

Janes, Victoria A., Sébastien Matamoros, Patrick Munk, et al.. (2022). Metagenomic DNA sequencing for semi-quantitative pathogen detection from urine: a prospective, laboratory-based, proof-of-concept study. The Lancet Microbe. 3(8). e588–e597. 17 indexed citations

Groot, T.L.C.M., Reinier M. van Hest, Caroline E. Visser, et al.. (2022). Detecting inappropriate total duration of antimicrobial therapy using semi-automated surveillance. Antimicrobial Resistance and Infection Control. 11(1). 110–110. 2 indexed citations

Buis, David T. P., Lilian J. Meijboom, Rogier P. Schade, et al.. (2021). Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study. Antimicrobial Resistance and Infection Control. 10(1). 155–155. 17 indexed citations

Prins, Jan M., Brent C. Opmeer, Marja A. Boermeester, et al.. (2017). Effect of an antibiotic checklist on length of hospital stay and appropriate antibiotic use in adult patients treated with intravenous antibiotics: a stepped wedge cluster randomized trial. Clinical Microbiology and Infection. 23(7). 485.e1–485.e8. 22 indexed citations

Visser, Caroline E., et al.. (2017). Antimicrobial prophylaxis outside the operating theatre, an audit in a university hospital. BMC Infectious Diseases. 17(1). 296–296. 4 indexed citations

Heer, Koen de, M. G. M. Kok, Aeilko H. Zwinderman, et al.. (2016). eNose technology can detect and classify human pathogenic molds in vitro : a proof-of-concept study of Aspergillus fumigatus and Rhizopus oryzae. Journal of Breath Research. 10(3). 36008–36008. 12 indexed citations

Prins, Jan M., Brent C. Opmeer, Marja A. Boermeester, et al.. (2015). A cluster randomized trial for the implementation of an antibiotic checklist based on validated quality indicators: the AB-checklist. BMC Infectious Diseases. 15(1). 134–134. 9 indexed citations

10.

Matamoros, Sébastien, Marianne A. van de Pol, Bob de Wever, et al.. (2015). Changes in microbiota during experimental human Rhinovirus infection. BMC Infectious Diseases. 15(1). 336–336. 33 indexed citations

11.

Gerritsen, Marije G., Paul Brinkman, Koen de Heer, et al.. (2014). Detection of invasive aspergillosis by an electronic nose platform: Preliminary data in a validation cohort. European Respiratory Journal. 44(Suppl 58). P256–P256. 1 indexed citations

12.

Kager, Liesbeth M., Paul Bresser, Jaring S. van der Zee, et al.. (2014). Pulmonary tuberculosis induces a systemic hypercoagulable state. Journal of Infection. 70(4). 324–334. 50 indexed citations

13.

Wassenberg, M.W.M., Jan Kluytmans, Ron Bosboom, et al.. (2011). Rapid diagnostic testing of methicillin-resistant Staphylococcus aureus carriage at different anatomical sites: costs and benefits of less extensive screening regimens. Clinical Microbiology and Infection. 17(11). 1704–1710. 30 indexed citations

14.

Jansen, Rogier R., Janke Schinkel, Sylvie M. Koekkoek, et al.. (2009). QUANTITATION OF RESPIRATORY VIRUSES IN RELATION TO CLINICAL COURSE IN CHILDREN WITH ACUTE RESPIRATORY TRACT INFECTIONS. The Pediatric Infectious Disease Journal. 29(1). 82–84. 32 indexed citations

15.

Leeflang, Mariska, Y. J. Debets-Ossenkopp, Caroline E. Visser, et al.. (2008). Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database of Systematic Reviews. CD007394–CD007394. 274 indexed citations

16.

Nurmohamed, Shaikh A., et al.. (2007). Hyperammonemia in Generalized Mycobacterium genavense Infection after Renal Transplantation. American Journal of Transplantation. 7(3). 722–723. 34 indexed citations

17.

Paltansing, S., et al.. (2007). Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. Clinical Microbiology and Infection. 13(11). 1058–1064. 94 indexed citations

18.

Gilhuis, H. Jacobus, Caroline E. Visser, & Peter Portegies. (2004). Recurrent Varicella-Zoster Virus Myelitis in an Immunocompetent Patient. European Neurology. 52(2). 121–122. 7 indexed citations

19.

Louwerse, Elisabeth S., Caroline E. Visser, Patrick M. Bossuyt, & Gerrit Jan Weverling. (1997). Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. Journal of the Neurological Sciences. 152. s10–s17. 87 indexed citations

20.

Visser, Caroline E., et al.. (1989). Microwave treatment of xenogeneic cartilage transplants. Biomaterials. 10(8). 507–510. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact